Oligometastatic Breast Cancer: Considering Patients One by One
SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.
Category
- Breast
- Oligometastatic
- SBRT
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Challenging Cases in Breast Cancer: Rare Breast Cancer Histologies and Presentations
This activity includes a panel of experts from breast radiation oncology, surgical oncology, medical oncology, and pathology to discuss the following rare histologies/breast cancer presentations: 1) Pleomorphic LCIS- diagnosis and differential (path) appropriate margin width (surgeon), role of ad
Category
- Breast
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Update on ASTRO's Partial Breast Irradiation Guidelines: Case-based Discussion
Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.
Category
- Breast
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment in a Community Setting

There are multiple new developments in the treatment of breast cancer patients with radiation therapy, as well as ongoing developments in the use of breast IMRT. Practicing clinicians need to stay informed to improve outcomes among breast cancer patients.
Category
- Breast
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?

This is a case-based panel activity, with a surgeon, a medical oncologist and a radiation oncologist. Each speaker reviews the current and ongoing studies addressing treatment de-intensification in their area of expertise.
Category
- Breast
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Salvage Therapy for Local-Regional Breast Cancer Recurrence: What, When, and How Much?

Breast cancer recurrence after prior definitive multimodality treatment is an increasingly common clinical situation faced by practitioners, with long-term new primary or recurrent non-metastatic locoregional recurrence developing not infrequently over 10 years following initial treatment.
Category
- Breast
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Sexuality After Cancer Therapy

Patient fertility and sexual complications have few data available from clinical trials. It is noteworthy that the subject is infrequently discussed in institutional peer reviews/ M&M unless there is a Risk Management overlay.
Category
- Breast
- Genitourinary
- Gynecologic
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00